<DOC>
	<DOC>NCT01419145</DOC>
	<brief_summary>A multicentre, open, randomized phase II study comparing a multimodal intervention (oral nutritional supplements, celecoxib and physical exercise) for cachexia versus standard cancer care.</brief_summary>
	<brief_title>A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study</brief_title>
	<detailed_description />
	<mesh_term>Cachexia</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Main eligibility criteria: Advanced nonsmallcell lung cancer (stage IIIIV) or pancreatic cancer not eligible for curative therapy Due to commence chemo or chemo radiotherapy Karnofsky Performance Score ≥ 70 A life expectancy of ≥4 months and considered able to complete 2 months of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>cachexia</keyword>
	<keyword>neoplasms</keyword>
	<keyword>complications</keyword>
	<keyword>combined modality therapy</keyword>
	<keyword>exercise therapy</keyword>
	<keyword>diet therapy</keyword>
	<keyword>anti-inflammatory agents</keyword>
</DOC>